Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.

Kaur M, Bhatia RK, Pissurlenkar RR, Coutinho EC, Jain UK, Katare OP, Chandra R, Madan J.

Carbohydr Polym. 2014 Jan 30;101:614-22. doi: 10.1016/j.carbpol.2013.09.077. Epub 2013 Sep 30.

PMID:
24299818
[PubMed - indexed for MEDLINE]
2.

Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.

Sangwai M, Vavia P.

Int J Pharm. 2013 Sep 10;453(2):423-32. doi: 10.1016/j.ijpharm.2012.08.034. Epub 2012 Aug 28.

PMID:
22935741
[PubMed - indexed for MEDLINE]
3.

An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.

Bandarkar FS, Vavia PR.

Drug Dev Ind Pharm. 2011 Nov;37(11):1318-28. doi: 10.3109/03639045.2011.572285. Epub 2011 Apr 21.

PMID:
21506882
[PubMed - indexed for MEDLINE]
4.

Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.

Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.

Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. Epub 2006 Nov 29.

PMID:
17240129
[PubMed - indexed for MEDLINE]
5.

Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.

Hu L, Zhang H, Song W, Gu D, Hu Q.

Carbohydr Polym. 2012 Nov 6;90(4):1719-24. doi: 10.1016/j.carbpol.2012.07.057. Epub 2012 Jul 31.

PMID:
22944438
[PubMed - indexed for MEDLINE]
6.

Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.

Lin SY, Hsu CH, Sheu MT.

J Pharm Biomed Anal. 2010 Nov 2;53(3):799-803. doi: 10.1016/j.jpba.2010.06.010. Epub 2010 Jun 19.

PMID:
20619996
[PubMed - indexed for MEDLINE]
7.

Molecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cells.

Madan J, Baruah B, Nagaraju M, Abdalla MO, Yates C, Turner T, Rangari V, Hamelberg D, Aneja R.

Mol Pharm. 2012 May 7;9(5):1470-80. doi: 10.1021/mp300063v. Epub 2012 Apr 27.

PMID:
22540277
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.

Qiu N, Cheng X, Wang G, Wang W, Wen J, Zhang Y, Song H, Ma L, Wei Y, Peng A, Chen L.

Carbohydr Polym. 2014 Jan 30;101:623-30. doi: 10.1016/j.carbpol.2013.09.035. Epub 2013 Sep 23.

PMID:
24299819
[PubMed - indexed for MEDLINE]
9.

Synthesis and evaluation of a novel β-cyclodextrin derivative for oral insulin delivery and absorption.

Zhang L, Zhang Z, Li N, Wang N, Wang Y, Tang S, Xu L, Ren Y.

Int J Biol Macromol. 2013 Oct;61:494-500. doi: 10.1016/j.ijbiomac.2013.08.034. Epub 2013 Aug 28.

PMID:
23994793
[PubMed - indexed for MEDLINE]
10.

Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.

Gundogdu E, Koksal C, Karasulu E.

Drug Dev Ind Pharm. 2012 Jun;38(6):689-96. doi: 10.3109/03639045.2011.621434. Epub 2011 Oct 19.

PMID:
22010782
[PubMed - indexed for MEDLINE]
11.

In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.

Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W.

Arch Pharm Res. 2007 Aug;30(8):991-1001.

PMID:
17879753
[PubMed - indexed for MEDLINE]
12.

Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.

Wang X, Deng L, Cai L, Zhang X, Zheng H, Deng C, Duan X, Zhao X, Wei Y, Chen L.

J Pharm Sci. 2011 Aug;100(8):3357-64. doi: 10.1002/jps.22534. Epub 2011 Mar 8.

PMID:
21387317
[PubMed - indexed for MEDLINE]
13.

Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.

Kim MS.

Int J Nanomedicine. 2013;8:2029-39. doi: 10.2147/IJN.S44795. Epub 2013 May 20.

PMID:
23737668
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.

Zhang Y, Jiang T, Zhang Q, Wang S.

Eur J Pharm Biopharm. 2010 Sep;76(1):17-23. doi: 10.1016/j.ejpb.2010.05.010. Epub 2010 Jun 2.

PMID:
20685333
[PubMed - indexed for MEDLINE]
15.

Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.

Badr-Eldin SM, Elkheshen SA, Ghorab MM.

Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.

PMID:
18655829
[PubMed - indexed for MEDLINE]
16.

Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.

Sinha VR, Nanda A, Chadha R, Goel H.

Acta Pol Pharm. 2011 Jul-Aug;68(4):585-92.

PMID:
21796941
[PubMed - indexed for MEDLINE]
Free Article
17.

Enhancement of solubility and permeability of Candesartan cilexetil by using different pharmaceutical interventions.

Shaikh SM, Avachat AM.

Curr Drug Deliv. 2011 Jul;8(4):346-53.

PMID:
21453263
[PubMed - indexed for MEDLINE]
18.

Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.

Ren K, Zhang Z, Li Y, Liu J, Zhao D, Zhao Y, Gong T.

Pharmazie. 2009 Aug;64(8):515-20.

PMID:
19746840
[PubMed - indexed for MEDLINE]
19.

Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.

Yin JJ, Sharma S, Shumyak SP, Wang ZX, Zhou ZW, Zhang Y, Guo P, Li CZ, Kanwar JR, Yang T, Mohapatra SS, Liu W, Duan W, Wang JC, Li Q, Zhang X, Tan J, Jia L, Liang J, Wei MQ, Li X, Zhou SF.

PLoS One. 2013 May 2;8(5):e62289. doi: 10.1371/journal.pone.0062289. Print 2013.

PMID:
23658721
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Comparison of the complexation between methylprednisolone and different cyclodextrins in solution by 1H-NMR and molecular modeling studies.

Thi TD, Nauwelaerts K, Froeyen M, Baudemprez L, Van Speybroeck M, Augustijns P, Annaert P, Martens J, Van Humbeeck J, Van den Mooter G.

J Pharm Sci. 2010 Sep;99(9):3863-73. doi: 10.1002/jps.22227.

PMID:
20665846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk